Document is current

Article History

Received: 28 May 2024

Accepted: 7 August 2024

First Online: 14 August 2024

Declarations

:

: This research was approved by the Institutional Review Board of the First People’s Hospital of Yunnan Province and carried out strictly in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants and from their legal guardians who were aged < 16 years. Data were stored and analyzed anonymously.1)population, place and period of study: In total, 4956 patients who were diagnosed with ARIs were continuously recruited at the First People’s Hospital of Yunnan Province from January 2020 to December 2022. The patients exhibited symptoms of acute respiratory tract diseases, including cough, sore throat, flu-like symptoms (such as fever, fatigue, headache, nasal congestion, and a runny nose), and difficulty breathing. The inclusion criteria were as follows: (1) age under 18 years; (2) diagnosis of an ARI; and (3) received no clinical treatment prior to sample collection. Importantly, for each patient, only the results of the first specimen were collected and analyzed during the course of the disease []. Patients with COVID-19 were excluded from the study. 2) Sample collection: Throat swabs were collected from each patient and stored in sterile sample tubes containing cell preservation solution (HEALTH Gene Technologies Co., Ltd., Ningbo, China). Specimens were transported, stored at 4℃, and tested for respiratory viruses within 24 h of collection.

: Not applicable.

: The authors declare no competing interests.